OutlookMy humble view: we have an investment here that's built on a very strong foundation. First, a management team of Doctors "with market experience", we also have a proposition that's "whole Patient" health which means they have built and acquired the ability to manage the entire patient ecosystem which is very unique in a sea of players that have pieces of it, we also have growth metrics that have kicked investor return off but its only just begun......next is, enterprise client deals and more key M&A ie geographic.......last, before COVID, CloudMD established itself in India and China BUT stalled further there because COVID gave them a NORTH AMERICA opportunity to advance things 10 years......so, if your an investor, you have 1) a proper telehealth proposition 2) we are at the beginning of a new era in healthcare 3) a massive global market so many quality players will succeed 4) timing.....its all about timing and we are here into 2021.....THERE ARE TWO RISKS in my mind, 1) can they sell? And 2) can they execute big ticket sales.......